Literature DB >> 10479770

Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro.

N Skottová1, V Krecman, V Simánek.   

Abstract

Silymarin, a standardized extract from Silybum marianum, inhibited in vitro the copper-induced oxidation of human LDL in a concentration-dependent manner. Silybin, a main flavonolignan of silymarin, appeared to be responsible for this LDL antioxidant effect. Silychristin and silydianin, other flavonolignans of silymarin, acted rather as pro-oxidants, but with regard to their content in silymarin, it did not contribute significantly to the reduction of the total LDL antioxidant capacity of silymarin. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479770     DOI: 10.1002/(sici)1099-1573(199909)13:6<535::aid-ptr526>3.0.co;2-w

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio).

Authors:  Rui Jia; Liping Cao; Jinliang Du; Pao Xu; Galina Jeney; Guojun Yin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-22       Impact factor: 2.416

2.  Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.

Authors:  Ruyue Lian; Yi Lu; Jianping Qi; Yanan Tan; Mengmeng Niu; Peipei Guan; Fuqiang Hu; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2011-09-23       Impact factor: 3.246

Review 3.  Current, new and future treatments in dyslipidaemia and atherosclerosis.

Authors:  P H Chong; B S Bachenheimer
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

4.  Assessment of the Antioxidant Activity of Silybum marianum Seed Extract and Its Protective Effect against DNA Oxidation, Protein Damage and Lipid Peroxidation.

Authors:  Aynur Serçe; Bircan Çeken Toptancı; Sevil Emen Tanrıkut; Sevcan Altaş; Göksel Kızıl; Süleyman Kızıl; Murat Kızıl
Journal:  Food Technol Biotechnol       Date:  2016-12       Impact factor: 3.918

5.  Development of a HPLC-UV assay for silybin-phosphatidylcholine complex (silybinin capsules) and its pharmacokinetic study in healthy male Chinese volunteers.

Authors:  Wei Li; Jun Gao; Hong-Zhi Zhao; Chang-Xiao Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

6.  Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats.

Authors:  Pragada Rajeswara Rao; Routhu Kasi Viswanath
Journal:  Exp Clin Cardiol       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.